Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial

Figure 2

The mean IOP for all patients in both groups at each visit, along with the “” values, demonstrating that there was no significant difference between the groups at any stage. 172 patients were available for all follow-ups up to one year. 12 patients in Group I and 14 in Group II completed two years of follow-up.